The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Fred Hutchinson Cancer Center-led investigators found that higher patient-reported fatigue before cancer treatment aligned ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.

Ramez N. Eskander, MD, discusses the heterogenous nature of endometrial cancer and molecular testing being used to identify appropriate patients for specific treatments. He also highlights what study ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen ...

Could diabetes medications have an influence beyond simply regulating blood sugar? This question is gaining ground in ...